Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of Medical Nutrition USA, Inc. - MDNU
June 11 2010 - 12:08PM
Business Wire
Levi & Korsinsky is investigating the Board of Directors of
Medical Nutrition USA, Inc. (“Medical Nutrition” or the “Company”)
(NasdaqCM: MDNU) for possible breaches of fiduciary duty and other
violations of state law in connection with their attempt to sell
the Company to Danone North America, Inc. ("Danone"). Under the
terms of the transaction, Medical Nutrition shareholders will
receive $4.00 in cash for each Medical Nutrition share of common
stock they own for a total transaction value of approximately $62.3
million.
For the year ending January 31, 2010, Medical Nutrition reported
total revenue of $16.089 million and net income of $483 thousand as
compared to total revenue and a net loss of $13.747 million and
$492 thousand, respectively, for the prior year. The investigation
concerns whether the Medical Nutrition Board of Directors breached
their fiduciary duties to Medical Nutrition stockholders by failing
to adequately shop the Company before entering into this
transaction and whether Danone is underpaying for Medical Nutrition
shares, thus unlawfully harming Medical Nutrition stockholders. In
particular, at least one analyst set a price target for Medical
Nutrition stock at $8.25 per share.
If you own common stock in Medical Nutrition and wish to obtain
additional information, please contact Joseph E. Levi, Esq. either
via email at jlevi@zlk.com or by telephone at (212) 363-7500 or
visit http://www.zlk.com/medical-nutrition-usa-mdnu.html.
Levi & Korsinsky has expertise in prosecuting investor
securities litigation and extensive experience in actions involving
financial fraud and represents investors throughout the nation,
concentrating its practice in securities and shareholder
litigation.
Medical Nutrition Usa (MM) (NASDAQ:MDNU)
Historical Stock Chart
From Oct 2024 to Nov 2024
Medical Nutrition Usa (MM) (NASDAQ:MDNU)
Historical Stock Chart
From Nov 2023 to Nov 2024